Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Avai Bio (AVAI) Income from Continuing Operations (2018 - 2024)

Avai Bio's Income from Continuing Operations history spans 6 years, with the latest figure at 4801438.0 for Q1 2024.

  • For Q1 2024, Income from Continuing Operations fell 738.05% year-over-year to 4801438.0; the TTM value through Mar 2024 reached 7437624.0, down 2031.53%, while the annual FY2025 figure was 1142115.0, 61.63% up from the prior year.
  • Income from Continuing Operations for Q1 2024 was 4801438.0 at Avai Bio, down from 1825043.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 417163.0 in Q4 2020 and bottomed at 4801438.0 in Q1 2024.
  • The 4-year median for Income from Continuing Operations is 184929.5 (2022), against an average of 645587.0.
  • The largest YoY upside for Income from Continuing Operations was 4203.92% in 2020 against a maximum downside of 1770.01% in 2020.
  • A 4-year view of Income from Continuing Operations shows it stood at 417163.0 in 2020, then plummeted by 73.52% to 110471.0 in 2022, then plummeted by 1752.06% to 1825043.0 in 2023, then crashed by 163.09% to 4801438.0 in 2024.
  • Per Business Quant, the three most recent readings for AVAI's Income from Continuing Operations are 4801438.0 (Q1 2024), 1825043.0 (Q4 2023), and 399621.0 (Q3 2023).